335 related articles for article (PubMed ID: 36132991)
1. Schisantherin A alleviates non-alcoholic fatty liver disease by restoring intestinal barrier function.
Yu S; Jiang J; Li Q; Liu X; Wang Z; Yang L; Ding L
Front Cell Infect Microbiol; 2022; 12():855008. PubMed ID: 36132991
[TBL] [Abstract][Full Text] [Related]
2. Luteolin alleviates non-alcoholic fatty liver disease in rats via restoration of intestinal mucosal barrier damage and microbiota imbalance involving in gut-liver axis.
Liu X; Sun R; Li Z; Xiao R; Lv P; Sun X; Olson MA; Gong Y
Arch Biochem Biophys; 2021 Oct; 711():109019. PubMed ID: 34478730
[TBL] [Abstract][Full Text] [Related]
3. Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease.
Wang W; Zhao J; Gui W; Sun D; Dai H; Xiao L; Chu H; Du F; Zhu Q; Schnabl B; Huang K; Yang L; Hou X
Br J Pharmacol; 2018 Feb; 175(3):469-484. PubMed ID: 29139555
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
5. The combination of Ilexhainanoside D and ilexsaponin A
Zhao W; Xiao M; Yang J; Zhang L; Ba Y; Xu R; Liu Z; Zou H; Yu P; Wu X; Chen X
Phytomedicine; 2019 Oct; 63():153039. PubMed ID: 31387054
[TBL] [Abstract][Full Text] [Related]
6. Sulforaphane Ameliorates Nonalcoholic Fatty Liver Disease Induced by High-Fat and High-Fructose Diet via LPS/TLR4 in the Gut-Liver Axis.
Xu Y; Huang X; Huangfu B; Hu Y; Xu J; Gao R; Huang K; He X
Nutrients; 2023 Feb; 15(3):. PubMed ID: 36771448
[TBL] [Abstract][Full Text] [Related]
7. Tangshen formula targets the gut microbiota to treat non-alcoholic fatty liver disease in HFD mice: A 16S rRNA and non-targeted metabolomics analyses.
Wang S; Li X; Zhang B; Li Y; Chen K; Qi H; Gao M; Rong J; Liu L; Wan Y; Dong X; Yan M; Ma L; Li P; Zhao T
Biomed Pharmacother; 2024 Apr; 173():116405. PubMed ID: 38484559
[TBL] [Abstract][Full Text] [Related]
8. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
Wang P; Wang J; Li D; Ke W; Chen F; Hu X
J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
[TBL] [Abstract][Full Text] [Related]
9. Oleuropein, a Component of Extra Virgin Olive Oil, Improves Liver Steatosis and Lobular Inflammation by Lipopolysaccharides-TLR4 Axis Downregulation.
Schirone L; Overi D; Carpino G; Carnevale R; De Falco E; Nocella C; D'Amico A; Bartimoccia S; Cammisotto V; Castellani V; Frati G; Sciarretta S; Gaudio E; Pignatelli P; Alvaro D; Violi F
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891768
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen inhalation ameliorates hepatic inflammation and modulates gut microbiota in rats with high-fat diet-induced non-alcoholic fatty liver disease.
Xue J; Zhao M; Liu Y; Jia X; Zhang X; Gu Q; Xie Y; Qin S; Liu B
Eur J Pharmacol; 2023 May; 947():175698. PubMed ID: 36997047
[TBL] [Abstract][Full Text] [Related]
11. Tectorigenin ameliorated high-fat diet-induced nonalcoholic fatty liver disease through anti-inflammation and modulating gut microbiota in mice.
Duan R; Huang K; Guan X; Li S; Xia J; Shen M; Sun Z; Yu Z
Food Chem Toxicol; 2022 Jun; 164():112948. PubMed ID: 35390440
[TBL] [Abstract][Full Text] [Related]
12. SIRT3 Deficiency Promotes High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Correlation with Impaired Intestinal Permeability through Gut Microbial Dysbiosis.
Chen M; Hui S; Lang H; Zhou M; Zhang Y; Kang C; Zeng X; Zhang Q; Yi L; Mi M
Mol Nutr Food Res; 2019 Feb; 63(4):e1800612. PubMed ID: 30525304
[TBL] [Abstract][Full Text] [Related]
13. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
[TBL] [Abstract][Full Text] [Related]
14. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.
Li X; Zhao W; Xiao M; Yu L; Chen Q; Hu X; Zhao Y; Xiong L; Chen X; Wang X; Ba Y; Guo Q; Wu X
J Ethnopharmacol; 2022 Aug; 294():115333. PubMed ID: 35500802
[TBL] [Abstract][Full Text] [Related]
15. Hepatobiliary and pancreatic: Multi-donor fecal microbiota transplantation attenuated high-fat diet-induced hepatic steatosis in mice by remodeling the gut microbiota.
Shou D; Luo Q; Tang W; Cao C; Huang H; Chen H; Zhou Y
J Gastroenterol Hepatol; 2023 Dec; 38(12):2195-2205. PubMed ID: 37787118
[TBL] [Abstract][Full Text] [Related]
16. A High-Fat Diet Increases the Characteristics of Gut Microbial Composition and the Intestinal Damage Associated with Non-Alcoholic Fatty Liver Disease.
Zhu X; Cai J; Wang Y; Liu X; Chen X; Wang H; Wu Z; Bao W; Fan H; Wu S
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069055
[TBL] [Abstract][Full Text] [Related]
17. Glucosamine Improves Non-Alcoholic Fatty Liver Disease Induced by High-Fat and High-Sugar Diet through Regulating Intestinal Barrier Function, Liver Inflammation, and Lipid Metabolism.
Li F; Zhang Z; Bai Y; Che Q; Cao H; Guo J; Su Z
Molecules; 2023 Oct; 28(19):. PubMed ID: 37836761
[TBL] [Abstract][Full Text] [Related]
18.
Tian G; Wang W; Xia E; Chen W; Zhang S
Front Cell Infect Microbiol; 2023; 13():1078447. PubMed ID: 36860985
[TBL] [Abstract][Full Text] [Related]
19. Hepatoprotective effect of curcumin against bisphenol A-induced hepatic steatosis via modulating gut microbiota dysbiosis and related gut-liver axis activation in CD-1 mice.
Hong T; Jiang X; Zou J; Yang J; Zhang H; Mai H; Ling W; Feng D
J Nutr Biochem; 2022 Nov; 109():109103. PubMed ID: 35780999
[TBL] [Abstract][Full Text] [Related]
20. Smilax China L. polysaccharide prevents HFD induced-NAFLD by regulating hepatic fat metabolism and gut microbiota.
Zhang W; Yu L; Yang Q; Zhang J; Wang W; Hu X; Li J; Zheng G
Phytomedicine; 2024 May; 127():155478. PubMed ID: 38452696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
